In a collaboration between the National Institute for Bioprocessing Research and Training (NIBRT) and the University of Kent, NIBRT welcomes Professor Mark Smales as its newest Principal Investigator. The partnership aims to enrich and expand NIBRT’s expertise in the field of bioprocessing research. Professor Smales’ appointment represents a pivotal step towards advancing the understanding of biotechnological products and processes, and, with a strong focus on ATMPs, reinforces NIBRT’s commitment to cutting-edge research in biopharmaceutical manufacturing.

“We are excited to welcome Professor Smales to our organisation. His exceptional research accomplishments and leadership in the field will undoubtedly enhance our research capabilities and contribute to our mission of helping the growth and development of the biopharma manufacturing industry by providing cutting edge training and research solutions. Professor Mark Smales shares our commitment to pushing the boundaries of knowledge and driving innovation, and we are confident that their contributions will be instrumental in shaping the future of biopharma manufacturing.”

Darrin Morrissey, CEO, NIBRT

Both institutions share closely aligned goals, making this collaboration mutually beneficial. By joining forces, this collaboration aims to tackle some of the most difficult challenges in biopharmaceutical manufacturing research. 

As a Principal Investigator at NIBRT, Professor Mark Smales will lead a team of talented researchers that promises to have a profoundly positive impact on the understanding of biotechnological products and processes, pushing the boundaries of science and leading the way to innovation in biopharma manufacturing.

“I am honoured to become a part of NIBRT and look forward to working alongside the exceptional researchers here. Together, we will continue to advance the frontiers of biopharmaceutical manufacturing and make a positive impact on society through our collective efforts.”

Professor Mark Smales, University of Kent